knowledge -WSS

knowledge

author：knowledge 2025-09-04 05:35:56 - browse：4

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Live blog: Hearing on CRISPR

WSS

Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Key Senate panel to consider PBM, drug pricing reform package

Medicare must police algorithms in Medicare Advantage, Dems say

OTC birth control: A brief history of over the counter pill design

explore

knowledge

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Drug repurposing or repositioning? The language matters

OTC birth control: A brief history of over the counter pill design

Wildfire smoke exposes gaps in outdoor worker protections

After Sarepta trial failure, Duchenne families brace for more debate

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

How one medical school became remarkably diverse

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

explore

What is microchimerism and how does it affect maternal health?

Bill would allow buprenorphine prescription for addiction via telehealth

Microsoft strikes partnership with Duke Health to advance health AI

Travis Kelce and the trap of celebrity vaccine endorsements

Medicare must police algorithms in Medicare Advantage, Dems say

Key Senate panel to consider PBM, drug pricing reform package

explore

knowledge

hotspot

entertainment